Sanofi (NASDAQ:SNY) Stock Price Up 0.6%

Sanofi (NASDAQ:SNYGet Rating)’s share price rose 0.6% during trading on Thursday . The company traded as high as $49.26 and last traded at $49.26. Approximately 28,872 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 2,119,409 shares. The stock had previously closed at $48.99.

SNY has been the topic of a number of analyst reports. Guggenheim lifted their price target on Sanofi from €121.00 ($126.04) to €127.00 ($132.29) in a research note on Monday, May 2nd. Barclays boosted their target price on Sanofi from €90.00 ($93.75) to €105.00 ($109.38) in a research note on Thursday, April 14th. Morgan Stanley boosted their target price on Sanofi from €110.00 ($114.58) to €112.00 ($116.67) in a research note on Friday, April 22nd. UBS Group boosted their target price on Sanofi from €118.00 ($122.92) to €119.00 ($123.96) and gave the company a “buy” rating in a research note on Tuesday, June 7th. Finally, Stifel Nicolaus assumed coverage on Sanofi in a research note on Monday, February 28th. They set a “buy” rating on the stock. Seven research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $108.83.

The company has a market capitalization of $123.36 billion, a PE ratio of 15.95, a PEG ratio of 1.24 and a beta of 0.49. The company has a 50 day moving average of $53.61 and a two-hundred day moving average of $51.89. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.44 and a quick ratio of 1.03.

Sanofi (NASDAQ:SNYGet Rating) last issued its quarterly earnings results on Thursday, April 28th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.15. The company had revenue of $10.85 billion for the quarter, compared to analysts’ expectations of $10.33 billion. Sanofi had a return on equity of 25.34% and a net margin of 17.15%. On average, equities analysts anticipate that Sanofi will post 4.13 EPS for the current year.

The company also recently declared an annual dividend, which was paid on Wednesday, June 8th. Investors of record on Thursday, May 5th were paid a $1.7968 dividend. The ex-dividend date of this dividend was Wednesday, May 4th. This represents a yield of 2.7%. Sanofi’s payout ratio is 40.78%.

Institutional investors have recently added to or reduced their stakes in the business. GHP Investment Advisors Inc. bought a new stake in Sanofi in the first quarter worth $26,000. Fairfield Bush & CO. bought a new stake in Sanofi in the first quarter worth $26,000. First Community Trust NA bought a new position in shares of Sanofi during the fourth quarter valued at $26,000. Pinnacle Bancorp Inc. lifted its holdings in shares of Sanofi by 49.0% during the first quarter. Pinnacle Bancorp Inc. now owns 587 shares of the company’s stock valued at $30,000 after purchasing an additional 193 shares in the last quarter. Finally, Ahrens Investment Partners LLC bought a new position in shares of Sanofi during the first quarter valued at $31,000. 12.82% of the stock is currently owned by institutional investors and hedge funds.

About Sanofi (NASDAQ:SNY)

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.

Recommended Stories

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with's FREE daily email newsletter.